About Us
BiomEdit is an innovator in microbiome research. Our mission is to create products that raise the bar for animal health.
Setting a
new standard
BiomEdit is pioneering new research techniques to explore the untapped potential of the microbiome. In an industry where dedication and brilliant creativity are table stakes, our science stands out.
Embracing
complexity to accelerate discovery
Our high-throughput microbiology platform paired with our AI-powered predictive algorithms allows us to generate new hypotheses with a much higher probability of success than traditional methods.
Our approach
Our name, BiomEdit, was carefully crafted to reflect our approach to science and innovation
At BiomEdit, we explore the ways that the health of animals, humans, and the environment are influenced by the populations of bacterial species they host. These populations are known as the "microbiome".
These microbiomes interact across individuals, species, and environments, creating a dynamic link that impacts their host and surroundings.
We take a holistic approach to identifying common patterns across these interactions to develop products that benefit animals, humans, and their shared habitats.
Much like how an editor works to improve a manuscript, we're able to “edit” the microbial population, applying an advanced understanding of the microbiome, microbial ecosystems, and synthetic biology.
Culture
Our guiding principles are more than just words
Click below to hear BiomEditors talk about how we put these values into practice.
We are consciously building a psychologically safe workplace community that allows for a diverse set of perspectives, talents, backgrounds, and experiences to be heard. We value every individual’s contribution, and all feel respected and encouraged to speak up.
We foster relationships that encourage trust, honesty, transparency, candor and respect both internally between colleagues, and externally with customers and partners.
We operate with efficiency at every level by actively working to simplify processes and master complexity. We are diligent and deliberate in our actions and remain focused on achieving our goals through rigorous prioritization.
We exemplify creativity and boldness in developing revolutionary technologies that exceed the expectations of our customers and the industry. We prioritize scientific excellence and every solution we deliver is supported by high quality data.
The history of
BiomEdit
At BiomEdit, our foundation is rooted in the successful history of Eli Lilly and Company and Elanco Animal Health, innovators in human and animal health
Elanco announces intention to carve out its microbiome platform and pipeline
BiomEdit is established as an independent entity based in Fishers, Indiana
Research collaboration announced with Atarraya to increase sustainability of shrimp farming and improve global food security
Aaron Schacht participates in the White House listening session on Harnessing Biotechnology and Biomanufacturing for Food & Agricultural Innovation
S&P Global Animal Health names BiomEdit best start-up in animal health
Announcement of long-term strategic research and commercial partnership with Nutreco for next-generation ultra-specialty feed additives called Biome-actives
BiomEdit closes Series A funding round at $37M
Chairman and Board of Directors appointed
Integrated drug discovery collaboration announced with the Indiana Biosciences Research Institute
Collaboration with Athian announced to develop sustainability protocols in methane-reducing products in development, as well as AMR and food safety risk reduction projects
BiomEdit receives $4.5M grant from the Bill and Melinda Gates Foundation to develop products that reduce methane emissions from cattle.
S&P Global announces Aaron Schacht as the winner of the 2023 Visionary CEO award